-
Development of a Fragment-Based Machine Learning Algorithm for Designing Hybrid Drugs Optimized for Permeating Gram-Negative Bacteria
Authors:
Rachael A. Mansbach,
Inga V. Leus,
Jitender Mehla,
Cesar A. Lopez,
John K. Walker,
Valentin V. Rybenkov,
Nicolas W. Hengartner,
Helen I. Zgurskaya,
S. Gnanakaran
Abstract:
Gram-negative bacteria are a serious health concern due to the strong multidrug resistance that they display, partly due to the presence of a permeability barrier comprising two membranes with active efflux. New approaches are urgently needed to design antibiotics effective against these pathogens. In this work, we present a novel topological fragment-based approach ("Hunting Fragments Of X" or "H…
▽ More
Gram-negative bacteria are a serious health concern due to the strong multidrug resistance that they display, partly due to the presence of a permeability barrier comprising two membranes with active efflux. New approaches are urgently needed to design antibiotics effective against these pathogens. In this work, we present a novel topological fragment-based approach ("Hunting Fragments Of X" or "Hunting FOX") to rationally "hunt for" chemical fragments that promote compound ability to permeate the outer membrane. Our approach generalizes to other drug design applications. We measure minimum inhibitory concentrations of compounds in two strains of Pseudomonas aeruginosa with variable permeability barriers and use them as an input to the Hunting FOX algorithm to identify molecular fragments responsible for enhanced outer membrane permeation properties and candidate molecules from an external library that demonstrate good permeation ability. Overall, we present proof of concept for a novel method that is expected to be valuable for rational design of hybrid drugs.
△ Less
Submitted 29 July, 2019;
originally announced July 2019.
-
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
Authors:
Peter Hraber,
Bette Korber,
Kshitij Wagh,
Elena E. Giorgi,
Tanmoy Bhattacharya,
S. Gnanakaran,
Alan S. Lapedes,
Gerald H. Learn,
Edward F. Kreider,
Yingying Li,
George M. Shaw,
Beatrice H. Hahn,
David C. Montefiori,
S. Munir Alam,
Mattia Bonsignori,
M. Anthony Moody,
Hua-Xin Liao,
Feng Gao,
Barton F. Haynes
Abstract:
Within-host genetic sequencing from samples collected over time provides a dynamic view of how viruses evade host immunity. Immune-driven mutations might stimulate neutralization breadth by selecting antibodies adapted to cycles of immune escape that generate within-subject epitope diversity. Comprehensive identification of immune-escape mutations is experimentally and computationally challenging.…
▽ More
Within-host genetic sequencing from samples collected over time provides a dynamic view of how viruses evade host immunity. Immune-driven mutations might stimulate neutralization breadth by selecting antibodies adapted to cycles of immune escape that generate within-subject epitope diversity. Comprehensive identification of immune-escape mutations is experimentally and computationally challenging. With current technology, many more viral sequences can readily be obtained than can be tested for binding and neutralization, making down-selection necessary. Typically, this is done manually, by picking variants that represent different time-points and branches on a phylogenetic tree. Such strategies are likely to miss many relevant mutations and combinations of mutations, and to be redundant for other mutations. Longitudinal Antigenic Sequences and Sites from Intrahost Evolution (LASSIE) uses transmitted-founder loss to identify virus "hot-spots" under putative immune selection and chooses sequences that represent recurrent mutations in selected sites. LASSIE favors earliest sequences in which mutations arise. With well-characterized longitudinal Env sequences, we confirmed selected sites were concentrated in antibody contacts and selected sequences represented diverse antigenic phenotypes. Practical applications include rapidly identifying immune targets under selective pressure within a subject, selecting minimal sets of reagents for immunological assays that characterize evolving antibody responses, and for immunogens in polyvalent "cocktail" vaccines.
△ Less
Submitted 4 August, 2015; v1 submitted 3 August, 2015;
originally announced August 2015.
-
Network Structure of Protein Folding Pathways
Authors:
Erzsebet Ravasz,
S. Gnanakaran,
Zoltan Toroczkai
Abstract:
The classical approach to protein folding inspired by statistical mechanics avoids the high dimensional structure of the conformation space by using effective coordinates. Here we introduce a network approach to capture the statistical properties of the structure of conformation spaces. Conformations are represented as nodes of the network, while links are transitions via elementary rotations ar…
▽ More
The classical approach to protein folding inspired by statistical mechanics avoids the high dimensional structure of the conformation space by using effective coordinates. Here we introduce a network approach to capture the statistical properties of the structure of conformation spaces. Conformations are represented as nodes of the network, while links are transitions via elementary rotations around a chemical bond. Self-avoidance of a polypeptide chain introduces degree correlations in the conformation network, which in turn lead to energy landscape correlations. Folding can be interpreted as a biased random walk on the conformation network. We show that the folding pathways along energy gradients organize themselves into scale free networks, thus explaining previous observations made via molecular dynamics simulations. We also show that these energy landscape correlations are essential for recovering the observed connectivity exponent, which belongs to a different universality class than that of random energy models. In addition, we predict that the exponent and therefore the structure of the folding network fundamentally changes at high temperatures, as verified by our simulations on the AK peptide.
△ Less
Submitted 7 May, 2007;
originally announced May 2007.
